Manufacturer record
Micro Formulations: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Micro Formulations (Himachal Pradesh) were declared Not of Standard Quality between July 2024 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MICTAB- 2302, Amoxycillin & Potassium Clavulanate Tablets I.P. (Moxkit-CV 625) (exp Aug 2026). DTL Jaipur (state lab) found it not of standard quality: The sample does not conform to the IP with respect to Assay of Clavulanic Acid (NIL) and Amoxycillin. Listed in the June 2026 alert.
Records by type
4 records linked to Micro Formulations in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin & Potassium Clavulanate Tablets I.P. (Moxkit-CV 625) | Batch MICTAB- 2302Mfg Mar 2025 · Exp Aug 2026 | The sample does not conform to the IP with respect to Assay of Clavulanic Acid (NIL) and Amoxycillin.Assay | DTL JaipurState lab | Jun 2026 |
| Amoxycillin & Potassium Clavulanate Tablets I.P | Batch MICTAB-2424Mfg Jun 2025 · Exp Nov 2026 | Test for Dissolution and Assay for Amoxycillin & Potassium ClavulanateAssay | RDTL, Bellary, KarnatakaState lab | Nov 2025 |
| Synclov-625 Tablets (Amoxycillin & Potassium Clavulanate Tablets IP) | Batch MICTAB-2120Mfg Jan 2025 · Exp Jun 2026 | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to the content of Clavulanic Acid in Potassium Clavulanate Diluted Dissolution for Clavulanic Acid and toDissolution | DTL ChennaiState lab | Apr 2025 |
| Amoxycillin & Potassium Claulanate Tablets I.P. (Zalmoxi-CV 625) | Batch MICTAB- 1602Mfg Mar 2024 · Exp Aug 2025 | Dissolution of Clavulanic Acid and also Assay of Clavulanic AcidAssay | RDTL GuwahatiCDSCO lab | Jul 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.